The global fluorescein angiography market size is expected to reach USD 617.4 million by the end of 2027, expanding at a CAGR of 2.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.
Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market
Fluorescein Angiography Market Report Highlights
• North America accounted for the largest share in 2019 owing to favorable reimbursement policies, high adoption rate of advanced technologies, and increasing prevalence of diabetic retinopathy
• By product, the market is segmented into devices, disposables, and accessories
• The devices segment captured the largest market size in 2019 and is expected to witness a CAGR of 3.0% over the forecast period
• Availability of hybrid devices and technological advancements such as auto-focus and integration with AI are major factors driving the devices segment
• Based on application, the market is segmented into macular edema, macular degeneration, macular pucker, ocular melanoma, diabetic retinopathy, and others
• Macular degeneration and diabetic retinopathy captured the largest market share in 2019
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market/request/rs1
Fluorescein Angiography Market Segmentation
Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:
Fluorescein Angiography Product Outlook (Revenue, USD Million, 2016 – 2027)
• Device
• Disposables
• Dye
• Film
• Accessories
Fluorescein Angiography Technology Outlook (Revenue, USD Million, 2016 – 2027)
• Digital
• Analog
Fluorescein Angiography Application Outlook (Revenue, USD Million, 2016 – 2027)
• Macular edema
• Macular degeneration
• Macular pucker
• Ocular melanoma
• Diabetic retinopathy
• Others
Fluorescein Angiography Regional Outlook (Revenue, USD Million, 2016 – 2027)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• Italy
• France
• Russia
• Asia Pacific
• China
• India
• Japan
• Malaysia
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Colombia
• Argentina
• Middle East & Africa
• UAE
• Qatar
• Saudi Arabia
• South Africa
List of Key Players of Fluorescein Angiography Market
• Carl Zeiss Meditec, Inc.
• NIDEK Co., Ltd.
• Kowa Company Ltd.
• Topcon Medical Systems, Inc.
• Optomed Oy (Ltd.)
• CenterVue SpA
• Canon, Inc.
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/450347/ibb
Browse More Related Report:
Angiography Devices Market Size, Share & Trends Analysis Report By Technology (X-Ray, MRA, CT), By Product (Angiography Systems, Contrast Media), By Procedure, By Application, And Segment Forecasts, 2019 – 2026
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market